RetractedArticleOncoTargets and therapy2018

Ablation of MCM10 using CRISPR/Cas9 restrains the growth and migration of esophageal squamous cell carcinoma cells through inhibition of Akt signaling.

Jie Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.